No Apparent Benefit of Preemptive Sorafenib Therapy in...

  • Main
  • 2018 / 03
  • No Apparent Benefit of Preemptive Sorafenib Therapy in...

No Apparent Benefit of Preemptive Sorafenib Therapy in Liver Transplant Recipients with advanced HCC on Explant

Satapathy, Sanjaya K., Das, Kanak, Kocak, Mehmet, Helmick, Ryan A., Eason, James D., Nair, Satheesh, Vanatta, Jason M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Transplantation
DOI:
10.1111/ctr.13246
Date:
March, 2018
File:
PDF, 266 KB
english, 2018
Conversion to is in progress
Conversion to is failed